DOCTORS in the US have claimed that a now controversial malaria drug does help patients diagnosed with the coronavirus.

They say medics should start giving the drug to patients after 91.7 per cent showed improvements on the drug.

A report published by the Association of American Physicians and Surgeons (AAPS) stated patients who were given hydroxychloroquine spent less time in the hospital than those given other forms of medication such as antiviral drug Avigan.

More than 2,300 patients were treated with hydroxychloroquine as part of the test and medics have now advised that doctors should not wait to use the medication on coronavirus patients after 91.7 per cent of patients finished the treatment plan with a “good outcome”.

This is while 4.4 per cent of patients tested had a poor virological outcome, and 4.3 per cent had a poor clinical outcome.

Of the 4.3 per cent of patients with a poor clinical outcome, ten were transferred to intensive care units, five patients died and 31 required ten or more days of hospital treatment.

The report stated: “Both poor clinical and virological outcomes were associated with patients taking selective beta-blocking agents.”

RELATED: Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patients, States Association of American Physicians and Surgeons (AAPS)

The new data also found that patients who had been treated with the drug spent less time on wards.

Those treated with the malaria drug spent three times less on wards than those treated with other medications.

Doctors at the AAPS also voiced their findings in a letter to the governor of Arizona, Doug Ducey.

Governor Ducey had previously penned an executive order forbidding prophylactic use of chloroquine or hydroxychloroquine unless the drugs had been peer-reviewed and evidence became available.

The group has therefore asked that the original order now be rescinded in light of the new data.

It claimed that waiting for larger clinical trials during a pandemic was a “Bayesian approach to the assessment of diagnostic and therapeutic probabilities”.

It also claimed that it would save lives and money.

So far the US has claimed there has been over 58,000 deaths from the virus with over one million cases. In the UK there has been over 21,000 deaths and over 161,000 cases, with the toll thought to actually be much higher as Public Health England can only report deaths in hospitals.

The FDA has given authorisation to some doctors in the US to use the drug on coronavirus patients, however a leading US expert said there was no evidence to support the use of the drug on coronavirus patients.

Dr Anthony Fauci said evidence in favour of using the drug was anecdotal and the FDA has also warned against the use of the drug outside of a hospital setting.

Despite a lack of final data, the AAPS has said doctors should continue to use the malaria drug.

The report produced by the AAPS included patient data for the Covid patients. 53.2 per cent of which were female and 46.8 per cent were male.

The study found that mortality rates were also lower for the patients that received the malaria drug.

See the original here:

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »